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Abstract
A novel microduplication syndrome involving various-sized contiguous duplications in 17p13.3 has recently been described,
suggesting that increased copy number of genes in 17p13.3, particularly PAFAH1B1, is associated with clinical features
including facial dysmorphism, developmental delay, and autism spectrum disorder. We have previously shown that patient-
derived cell lines from individuals with haploinsufficiency of RPA1, a gene within 17p13.3, exhibit an impaired ATR-
dependent DNA damage response (DDR). Here, we show that cell lines from patients with duplications specifically
incorporating RPA1 exhibit a different although characteristic spectrum of DDR defects including abnormal S phase
distribution, attenuated DNA double strand break (DSB)-induced RAD51 chromatin retention, elevated genomic instability,
and increased sensitivity to DNA damaging agents. Using controlled conditional over-expression of RPA1 in a human model
cell system, we also see attenuated DSB-induced RAD51 chromatin retention. Furthermore, we find that transient over-
expression of RPA1 can impact on homologous recombination (HR) pathways following DSB formation, favouring
engagement in aberrant forms of recombination and repair. Our data identifies unanticipated defects in the DDR associated
with duplications in 17p13.3 in humans involving modest RPA1 over-expression.
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Introduction
Variously sized contiguous deletions within 17p13.3-pter are
associated with complex clinical features in humans including
structural brain abnormalities (lissencephaly, agyria, microcepha-
ly), growth retardation and developmental delay [1]. Multiple
pathogenomic studies have identified haploinsufficiency of genes
including PAFAH1B1 (LIS1) and YWHAE (14-3-3e) as being
particularly relevant in this context [2–5]. Previously, we have
shown that patients with haploinsufficiency of RPA1 exhibit
defective ATR-dependent DDR including failure of the G2-M cell
cycle checkpoint suggesting RPA1 is sensitive to copy number
variation [6]. Defective ATR-dependent G2-M arrest is associated
with human conditions characterised by severe microcephaly (e.g.
Seckel syndrome, Microcephalic primordial dwarfism type II,
MCPH1-dependent Primary microcephaly, Nijmegen breakage
syndrome) [7]. RPA1 (RPA1: RPA-70KD) encodes the largest
subunit of the Replication Protein A complex, a heterotrimeric
complex (RPA1-2-3: RPA-70KD-RPA-32KD-RPA14KD respec-
tively) with single stranded DNA binding capability that appears to
be involved in multiple DNA transactions. It functions to prevent
unregulated nuclease digestion and/or hairpin formation as well as
orchestrating the sequential assembly and disassembly of various
DNA processing factors during DNA replication, repair and
recombination [8–10]. With respect to the DDR, the DNA single
stranded binding function of RPA1–3 plays a fundamental role in
the recruitment of ATR to sites of DNA damage, for example
stalled replication forks, via a direct interaction with ATR’s
binding partner, ATRIP [11]. Furthermore, through interactions
with RAD51 and RAD52, RPA1–3 also plays an essential role in
homology directed recombinational repair, likely facilitating
RAD51 nucleofilament formation allowing strand invasion and
homology searching [12–16].
Recently, distinct, variously sized, non-recurrent duplications within
17p13.3 have been identified in several individuals defining a novel
genomic disorder. In two of these the duplication included RPA1 [17].
Consistent with other genomic disorders, the clinical duplication
phenotype appears to be less severe compared to deletions within
17p13.3. Nevertheless, subtle over-expression of ‘normal’ genes within
17p13.3 is associated with profound clinical consequences [17–19].
Interestingly, over-expression of RPA1 has been implicated in genomic
instability in other systems. For example, a quantitative over-expression
screen in the budding yeast Saccharomyces cerevisiae found that over-
expression of RFA1, the S. cerevisiae equivalent of mammalian RPA1,
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was associated with delayed cell cycle progression through G2-M,
impaired chromosomal spindle attachment and activation of the DDR
[20]. Furthermore, ectopic over-expression of individual RPA1–3
subunits in the human colorectal carcinoma cell line HCT116
promoted endoreduplication and aneuploidy [21]. Whether RPA1–3
over-expression functionally contributes to any cellular or clinical
phenotype associated with genomic disorders has not been investigat-
ed. Since we had previously observed specific DDR-defects associated
with reduced RPA1 expression in cell lines derived from individuals
with variously sized contiguous deletions at 17p13.3-pter, we sought to
determine if increased levels of RPA1 are associated with identical
and/or related DDR-defects [6]. Herein, we show that cell lines
derived from patients with 17p13.3 duplications that encompass RPA1
exhibit modest RPA1 over-expression, abnormal S phase distribution,
attenuated DSB-induced RAD51 chromatin retention and enhanced
sensitivity to killing by camptothecin, consistent with compromised
homologous recombination (HR). Using various model and reporter
systems we demonstrate that subtle over-expression of RPA1 is indeed
associated with altered HR-mediated DNA double strand break repair.
Results
Genomic duplications in 17p13.3 incorporating RPA1 are
associated with RPA1 over-expression
Two of the 17p13.3 duplication cases recently described by Bi et
al involve genomic duplication of RPA1, amongst other genes [17].
A schematic representation of the various CNVs in this region in
several cell lines used in this study is shown in Figure 1A. The cell
lines involving RPA1 duplication, BAB2668 and BAB2719, are
shown in red (Figure 1A).
We examined RPA1 expression by western blotting following
careful titration of whole cell extracts to ascertain the extent of
over-expression at the protein level using EBV-transformed
lymphoblastoid cells (LBLs) from both RPA1-duplication cases,
compared to another LBL with a 17p13.3 duplication that does
not involve RPA1 (BAB2721), as reported by Bi et al [17], and to an
LBL (BAB2751; Case 6 [17]) exhibiting a novel 17p13.3 genomic
deletion involving haploinsufficiency of RPA1 (Figure 1B). The left-
hand panel of Figure 1B shows that RPA1 protein is modestly
over-expressed in whole cells extracts from BAB2668 (Case 4 [17])
and BAB2719 (Case7 [17]) compared to BAB2721, an LBL from a
patient who does not exhibit RPA1 duplication at the genomic
level. LBLs from patient BAB2751 (Del; deleted for one copy of
RPA1) associated with genomic haploinsufficiency of RPA1 show
modestly reduced RPA1 expression at the protein level. Interest-
ingly, modest over-expression of RPA2 was also evident in whole
cell extracts from BAB2719 (Dup) and BAB2668 (Dup) (Figure 1B
middle panels). This suggests that the 17p13.3 duplications
involving RPA1 and resulting in RPA1 over-expression in these
cells likely also results in elevated levels of the RPA complex since
RPA2 levels appear modestly elevated in these cells (Figure 1B and
1C). Quantification of three separate experiments relative to
MCM2 is shown in Figure 1C. Similar data from the other LBLs
as described in Figure 1A is shown in Figure S1.
Normal G2-M and spindle assembly checkpoint
activation in 17p13.3 duplication syndrome associated
with RPA1 over-expression
An important role of RPA1–3 in the ATR-dependent DDR is
the recruitment of ATR-ATRIP to single stranded DNA (ssDNA)
generated at the DNA damage site, thereby initiating ATR-
dependent signalling [11,22]. One aim of this process is the
activation of cell cycle checkpoint arrest, particularly at the G2-M
transition. Previously, we have shown that Miller-Dieker Syn-
drome (MDS) and severe Isolated Lissencephaly Sequence (ILS+)
patient-derived LBLs with RPA1 haploinsufficiency fail to activate
the ATR-dependent G2-M checkpoint [6]. Furthermore, we
showed that this cellular phenotype was RPA1-dependent since it
could be complemented by ectopic expression of RPA1 following
transfection [6]. Interestingly, precedent exists whereby over-
expression of a DDR-component is actually associated with a
functional defect in the DDR [23–28]. Nevertheless, we did not
observe a defective ATR-dependent G2-M cell cycle checkpoint
arrest in LBLs derived from individuals with increased RPA1
levels associated with RPA1 duplication (Figure 2A). This was in
contrast to LBLs exhibiting RPA1 haploinsufficiency with reduced
RPA1 expression (BAB2751; Del; deleted for one copy of RPA1.
Figure 2A and [6]). Therefore, modest over-expression of RPA1 in
the context of 17p13.3 duplication is not associated with the same
ATR-dependent DDR-defect as that of RPA1 haploinsufficiency.
Since ectopic over-expression of RPA1 has previously been
shown to induce other forms of genomic instability including
aneuploidy, we examined spindle assembly checkpoint (SAC)
proficiency following prolonged exposure to the spindle poison
nocodazole in RPA1-duplicated patient-derived LBLs [21].
Following 24 hrs treatment with 1.5 mM nocodazole, cells with a
functional SAC exhibit an increased 4N population without any
progression to .4N, as demonstrated by the propidium iodide
staining flow cytometry profiles shown in Figure 2B (Unt;
untreated. Noc; nocodazole treated). Quantification of the 4N
population, with or without 24 hrs treatment with nocodazole,
demonstrates that BAB2752 (WT; wild-type RPA1 copy number),
BAB2668 (Dup; RPA1 duplication) and BAB2719 (Dup) all exhibit
a similar arrest at 4N following nocodazole (Figure 2C). No
increase in .4N was seen in either of the RPA1-duplicaiton
containing LBLs, BAB2668 or BAB2719 (Figure 2B). Hence, we
observed a normal nocodazole-induced arrest at mitosis with 4N
DNA content suggestive of a proficient SAC in this context.
Author Summary
The widespread use of genomic array technology has lead
to the identification of a plethora of novel human genomic
disorders. These complex conditions occur as a conse-
quence of structural genomic alterations (deletions,
amplifications, complex rearrangements). Understanding
the specific consequences of such alterations on gene
expression and unanticipated impacts on biochemical
pathways represents an important challenge to help
untangle the clinical basis of these conditions and
ultimately aid in their management. Here, we demonstrate
that individuals with specific duplications of 17p13.3
incorporating RPA1 exhibit modest over-expression of
RPA1. Unexpectedly, this is associated with elevated levels
of genomic instability and sensitivity to DNA damage.
RPA1 is a component of the Replication Protein A
heterotrimer, a complex that plays fundamental roles in
DNA replication, repair, and recombination. Reduced RPA1
levels are associated with impaired DNA damage check-
point activation, but the cellular impacts of over-expres-
sion of this subunit have not previously been described in
the context of a genomic disorder. Using model cell and
reporter systems, we show that modestly elevated levels of
RPA1 can adversely impact on DNA double-strand break–
induced homologous recombination resulting in elevated
levels of chromosome fusions. This data highlights an
unanticipated consequence of copy number variation on
genomic stability.
Increased RPA1 Gene Dosage and Genomic Disease
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Abnormal S-phase distribution associated with RPA1
over-expression in 17p13.3 duplication syndrome
Ectopic over-expression of RPA1 is associated with endoredupli-
cation in certain cell lines [21]. Since RPA1–3 complex is a
fundamental component of normal DNA replication we examined
S phase in one of our patient-derived LBLs with RPA1 duplication
(BAB2668) using bromodeoxyuridine (BrdU) pulse-labelling-cou-
pled two-dimensional flow cytometry (Figure 3A). No evidence for
spontaneous endoreduplication was found (data not shown). Whilst we
did not observe a difference in the overall amount of BrdU
incorporated between patient-derived LBL BAB2668 (Dup; with
RPA1 duplication) compared to those with normal (BAB2752;WT)
or haploinsufficient RPA1 copy number (BAB2751;Del) (Figure 3A
left hand graph), the distribution or pattern of BrdU labelling was
specifically and reproducibly altered in BAB2668 LBLs with RPA1
duplication (Figure 3A middle flow cytometry panels). The BrdU
positive cells within the boxed area represent those that have DNA
content between 2N and 4N (mid S phase) but have not
incorporated BrdU efficiently. These cells (i.e. mid S phase yet
low BrdU incorporation) are approximately 3–4 fold more
abundant in BAB2668 (Dup; RPA1 duplicated) compared to
BAB2752 (WT; RPA1 copy no) or BAB2751 (Del; haploinsufficient
RPA1) (Figure 3A right hand graph). This is suggestive of a
stochastic problem in S phase progression or DNA replication in
unperturbed asynchronously growing LBLs with RPA1 duplication.
RPA1 over-expressing 17p13.3 duplication syndrome
cells exhibit delayed recovery from arrest in S-phase
We next examined the ability of our patient-derived LBLs to
recover DNA replication following prolonged treatment with the
DNA polymerase inhibitor aphidicolin (APH). APH treatment for
24 hrs efficiently reduced total BrdU incorporation as expected for
Figure 1. Duplication of RPA1 results in RPA1 and RPA2 over-expression. (A) Schematic showing the copy number variation (CNV) of the
various patient-derived lymphoblastoid cell lines (LBLs) used in this study. The ‘Case’ numbers serve as identifiers for the patients described by Bi et al
[17]. The two lines associated with RPA1 duplication are highlighted in red. BAB2751 (in blue) exhibits haploinsufficiency involving RPA1 (in 100% of
cells), as previously described by Nagamani et al [37]. This case also exhibits a heterozygous deletion of 1–6.867 Mb in 40% of cells by FISH [37]. (B)
Western blot analysis for expression of RPA1 (left-hand panel) and RPA2 (middle panel) with MCM2 (right-hand panel) as a loading control. Whole cell
extracts were prepared using urea-buffer from patient derived LBLs. BAB2721 (WT; wild-type RPA1 copy number) is an LBL from a patient with a
duplication in 17p13.3 not involving RPA1 (case 6 Figure 1A). Both BAB2719 (Dup; RPA1 duplication) and BAB2668 (Dup) exhibit duplications
involving RPA1, whilst BAB2751 (Del; RPA1 heterozygous deletion) exhibits RPA1 haploinsufficiency. Each panel shows sequential loading of 2.5 mg,
5 mg and 10 mg extract. (C) Quantitative expression analysis of RPA1 and RPA2, standardised to MCM2 expression and normalised to BAB2721 (WT).
Measurements were taken directly from the membrane during ECL development using the Image Quant LAS 4000 luminescent image analyser and
Image Quant TL7.01 quantification software, so as to ensure signals were in the linear range.
doi:10.1371/journal.pgen.1002247.g001
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all cell lines (Figure 3B upper panels). When this APH-induced
DNA replication block was removed we found that RPA1-
duplication associated LBL BAB2668 (Dup) failed to progress as
efficiently as the control LBL BAB2752 (WT) through S phase, as
judged by the distribution of BrdU positive cells in late S phase as
indicated by the boxed area in Figure 3B (lower panels and graph).
This is consistent with a constitutional problem in the ability to
efficiently complete DNA replication, in this case following
recovery from replicative stress, in these patient-derived cells.
Interestingly, RPA1 haploinsufficiency (BAB2751) conferred a
similar phenotype (Figure 3B).
Ionising radiation (IR)–induced RPA1, RPA2, and RAD51
chromatin retention is attenuated in RPA1 over-
expressing 17p13.3 duplication syndrome cells
Since the RPA1–3 complex is also an important functional
component of HR, we sought to examine HR in our patient-
derived LBLs. Furthermore, defective HR has previously been
shown to result in impaired S phase progression, a phenotype
suggested by our BrdU incorporation data (Figure 3) [29,30].
Following IR treatment, we found modestly increased chromatin
binding of RPA1, RPA2 and RAD51 in LBLs with normal RPA1
copy number (BAB2705; WT), in contrast to chromatin extracts
from RPA1-duplicated BAB2668 LBLs (Dup) (Figure 4A and 4B).
In fact, BAB2668 (Dup) exhibited increased endogenous levels of
chromatin bound RPA1, RPA2 and RAD51, even in undamaged
cells, in contrast to the WT LBLs, but this level did not change
following IR (Figure 4A and 4B). Protein quantifications
standardised to histone H2B loading and normalised to the un-
irradiated BAB2705 (WT) for each of RPA1, RPA2 and RAD51
from three separate experiments are shown in Figure 4B. The
attenuated IR-induced RAD51 chromatin retention observed in
BAB2668 (Dup) indicates a potential problem in the ability to
induce RAD51-dependent HR in these cells following IR-induced
DSB formation.
Since the patient-derived LBLs with increased RPA1 copy
number are also duplicated for other genes, it was important to
examine whether indeed RPA1 is the protein conferring this
phenotype or whether it is in fact the consequence of combined
increased copy number of several genes. To demonstrate that this
cellular phenotype was specifically associated with RPA1 over-
expression, we constructed a conditional, isopropyl b-D-1-
thiogalactopyranoside (IPTG)-inducible-RPA1 model system in
the human glioblastoma line T98G based on the pTUNE vector
(Origene). Interestingly, we found that transient ectopic over-
expression of RPA1 from a high expression level CMV-promoter-
containing pcDNA3.1 mammalian expression vector was consis-
Figure 2. The ATR-dependent G2-M cell cycle checkpoint and the spindle assembly checkpoint (SAC) are functional in 17p13.3
duplication syndrome LBLs associated with RPA1 duplication. (A) ATR-dependent UV-induced G2-M checkpoint arrest as determined by
mitotic index (MI) is normal in LBLs associated with RPA1 over-expression, BAB2719 (Dup; RPA1 duplication), or with normal wild-type (WT) RPA1 copy
number (AG87 and BAB2678), in contrast to those exhibiting RPA1 haploinsufficiency, BAB2751 (Del; RPA1 heterozygous deletion). AG87 is a LBL from
a normal wild-type (WT) individual. A functional checkpoint arrest is indicated in a reduced MI following UV-treatment. Unt; untreated, UV; UV-
irradiated 5 J/m2 24 hrs. Data represents the mean 6 sd of three experiments. (B) Propidium iodide-derived flow cytometry profiles from LBLs either
untreated (Unt) or following 24 hrs 1.5 mM nocodazole (Noc). BAB2752 (WT; wild-type) is an LBL from the unaffected parent of BAB2751 (Figure 1A),
whilst BAB2668 (Dup; RPA1 duplication) and BAB2719 (Dup; RPA1 duplication) both exhibit RPA1 over-expression (Figure 1B). A functional SAC is
indicated by increased 4N DNA content following nocodazole treatment (Noc) compared to untreated (Unt), without an associated increase in cells
with.4N. (C) Quantification of the 4N DNA content of the untreated (Unt) and nocodazole treatment (Noc; 24 hrs 1.5 mM) LBLs shown in (B) showing
a nocodazole-induced increase in all of the LBLs examined indicative of a functional SAC irrespective of RPA1 copy number. Data represents the mean
6 sd of three experiments.
doi:10.1371/journal.pgen.1002247.g002
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tently associated with overt toxicity (associated with detectable
activated caspase 3; data not shown) in multiple commonly employed
human tumour lines (e.g. HeLa, MG63, A549) suggesting that
strong over-expression of RPA1 is not tolerated. We found
significant leakiness associated with the T98G-RPA1 system
(pTUNE-RPA1) as RPA1 and RPA2 levels appeared increased
even in the absence of IPTG (Figure 4C). Nevertheless, IPTG
treatment did induce a modest elevated expression of RPA1 in this
context (Figure 4C Unt; untreated. IPTG; IPTG treated).
Interestingly, this was also associated with elevated RPA2
expression (Figure 4C), similar to what was found in the patient-
derived LBLs (Figure 1B and 1C).
We found that the modest IPTG-induced over-expression of
RPA1 was associated with attenuated IR-induced chromatin
retention of both RPA1 and RAD51 (Figure 4D). Attenuated IR-
induced RAD51 chromatin retention is also a feature of the
patient-derived LBLs (Figure 4A and 4B). Furthermore, and
similar to LBLs exhibiting RPA1 duplication (BAB2668;
Figure 4A), we observed more chromatin associated RPA1 even
in undamaged cells following induction with IPTG (Figure 4D).
Collectively these data suggest that modest over-expression of
RPA1 is associated with attenuated RAD51 chromatin recruit-
ment following IR treatment and that this cellular phenotype is
observed in LBLs from patients with duplications in 17p13.3
involving RPA1 (Figure 4A).
RPA1 over-expression affects I-Sce I–induced HR
To gain direct, independent insight into the consequences of
subtle RPA1 over-expression on DSB-induced HR, we exploited
I-Sce I restriction enzyme-induced HR using the established
Figure 3. RPA1-duplication associated patient LBLs exhibit impaired DNA replication. (A) Left hand graph; Quantification of two
dimensional flow cytometry using BrdU pulse labelling (15 mins in 50 mM BrdU) followed by immunodetection shows that the level of BrdU
incorporation is equivalent for all LBLs tested irrespective of their RPA1 copy number. Approximately 35–40% of cells from all lines incorporated BrdU
following this pulse. Middle flow cytometry panels: The blue box indicates cells in mid-S phase (between 2N and 4N DNA content) that have
inefficiently incorporated BrdU. Right hand graph: The relative amount of BrdU positive cells within the boxed area compared to total S phase (total
BrdU positive cells). As a % of cells in S phase for each LBL following this pulse this amounts to approximately 5.7% for BAB2752 (WT), 18.7% for
BAB2668 (RPA1 duplication) and 2.7% for BAB2751 (RPA1 haploinsufficient). Data represents the mean 6 sd of three experiments. (B) Upper flow
cytometry panels: Aphidicolin (APH; 10 mM 24 hrs) treatment dramatically inhibits BrdU incorporation equivalently in all LBLs as expected. Lower flow
cytometry panels: 4 hrs after washing out of APH cells were pulse labelled with BrdU (15 mins 50 mM). The blue box indicates cells in late-S phase.
Right hand graph: The relative amount of BrdU positive cells within the boxed area compared to total S phase (total BrdU positive cells). Both
BAB2668 (RPA1 duplication) and BAB2751 (RPA1 haploinsufficient) LBLs show less incorporation of BrdU compared to BAB2752 (WT). Data represents
the mean 6 sd of three experiments.
doi:10.1371/journal.pgen.1002247.g003
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model DRneo reporter system in Chinese Hamster Ovary
(CHO) cells following transient over-expression of human native
untagged RPA1. Unlike other commonly used model HR
reporter systems (e.g. DR-GFP), we opted to use this set-up
specifically because the DRneo system enables the collective
assessment of alternative forms of recombination alongside gene
conversion (GC), such as single strand annealing (SSA)
(Figure 5A) [31–33]. This is a heterologous system, although
similar approaches have been used successfully before to study
HR-mediated DSB-repair ([30] and references therein). Unfor-
tunately, since the available RPA1 antibodies fail to cross-react
with hamster RPA1, it was difficult to determine the precise
extent of RPA1 over-expression following transient transfection.
Nevertheless, transient expression of the human protein under
these conditions appeared only modestly greater than endoge-
nous RPA1 expression in T98G cells (Figure 5B). Interestingly,
RPA1 expression in this context did not appear to grossly affect
GC, although the limitations of such as heterologous system
should be kept in mind (Figure 5C; white bars). Nevertheless, a
reduced expression-induced RPA-dependent phenotype has
been shown to give a different outcome using a similar system
arguing against a simple dominant-negative effect here [16].
However, unexpectedly, we observed an approximately 2-fold
increase in total levels of HR (i.e. all forms of GC+SSA; black
Figure 4. Modest RPA1 over-expression is associated with attenuated IR–induced RAD51 chromatin retention. (A) Impaired ionising
radiation (IR)-induced RPA1, RPA2 and RAD51 chromatin retention in LBLs associated with RPA1 duplication. LBLs with wild-type (WT) RPA1 copy
number (BAB2705) exhibit increased levels of chromatin bound RPA1, RPA2 and RAD51 following IR, in contrast to BAB2668 (Dup; RPA1 duplication).
Unt; untreated and IR; 24 hrs 10 Gy ionising radiation. Elevated chromatin bound RPA1, RPA2 and RAD51 is also evident in untreated (Unt) BAB2668
(Dup) relative to untreated (Unt) BAB2705 (WT), similar to the trend observed from whole cell extracts in Figure 1B and 1C. (B) Quantification of the
relative expression of RPA1, RPA2 and RAD51 standardized to histone H2B levels and normalized to untreated (Unt) BAB2705 (WT; wild-type RPA1
copy number). IR; ionizing radiation (10 Gy, 24 hrs). Data represents the mean 6 sd of three experiments. Data was obtained using the Image Quant
LAS 4000 luminescent image analyser. (C) T98G pTUNE-RPA1 containing cells (pTUNE-RPA1) exhibit a modestly increased basal level of RPA1 and
RPA2 compared to the parental T98G line (WT) likely suggestive of significant inherent leakiness of this conditional system (Unt; untreated).
Nevertheless, following isopropyl b-D-1-thiogalactopyranoside (IPTG) treatment (IPTG; 500 mM 3 hrs) a further subtle increase in RPA1 expression is
detectable. Whole cell extracts were prepared by detergent lysis and blot signals were quantified on Image J, standardized to histone H2B loading
and normalized to untreated (Unt) wild-type (WT). Data represents the mean 6 sd from three separate blots. (D) pTUNE-RPA1 cells either without
IPTG induction (2IPTG) or induced with IPTG (+IPTG) as in (C), were either left un-irradiated (Unt) or irradiated with 10 Gy ionising radiation (IR) and
chromatin extracts prepared 24 hrs post-irradiation. Increased chromatin bound RPA1 and RAD51 was observed in the IR-treated (IR) non-induced
(2IPTG) cells. IPTG induction (+IPTG) resulted in elevated RPA1 chromatin retention even in un-irradiated cells (Unt). These levels were not further
elevated following IR-treatment (+IPTG, IR). Similarly, RAD51 chromatin retention was not affected following IR-treatment of the IPTG-induced cells
(+IPTG, IR) relative to their un-irradiated counterpart (+IPTG, Unt). Although in this case, unlike in the patient-derived LBLs (A), spontaneously elevated
chromatin bound RAD51 was not evident over that of the un-induced cells (2IPTG). Blot signals were quantified on Image J, standardized to histone
H3 loading and normalized to untreated non-induced sample (2IPTG, Unt). Data represents the mean 6 sd from three separate blots.
doi:10.1371/journal.pgen.1002247.g004
Increased RPA1 Gene Dosage and Genomic Disease
PLoS Genetics | www.plosgenetics.org 6 August 2011 | Volume 7 | Issue 8 | e1002247
bars) following I-Sce I-induced DSB formation (Figure 5C and
5D). This implies that RPA1 over-expression following I-Sce I-
induced DSB results in increased forms of recombination such as
SSA and/or GC with crossing-over which can be regarded as an
aberrant or less favourable forms of recombination since they are
associated with loss of genetic material [29]. Interestingly, RPA
has recently been shown to be required for SSA in Xenopus
[34]. Furthermore, increased RAD51 expression is also associ-
ated with increased genomic instability using a similar HR
reporter system suggesting that over-expression of functional
components of repair pathways likely to be involved in repairing
such DSB’s can adversely affect repair [35]. These data are
consistent with attenuated IR-induced RAD51 chromatin
recruitment observed in the RPA1-duplication associated pa-
tient-derived LBLs (Figure 4A) and the T98G-RPA1 system
(pTUNE-RPA1; Figure 4D). Collectively, these results suggest
that modest increased expression of RPA1 can influence HR
sub-pathway choice.
Figure 5. RPA1 over-expression results in a hyper-recombinogenic phenotype. (A) A schematic of the DRneo system for I-Sce I-induced HR
based upon the reconstitution of a neomycin/G418 (Neo) cassette (S2neo joined to 39neo). The retention of the hygromycin resistance gene (HygR) in
this system distinguishes between gene conversion (GC) without crossing-over and alternative forms of recombination including single strand
annealing (SSA) and GC involving cross-over (intrachromatid crossing-over). NeoR; G418 resistance. HygR/S; hygromycin resistance/sensitivity. The repair
events monitored by DRneo include GC (HygR+NeoR), SSA (NeoR), GC involving intrachromatid crossing-over (NeoR) and non-homologous end joining
although this will not involve recovery of an intact Neo gene and are not recovered here (HygR). Sister chromatid exchanges (SCE) are not usually an
outcome of a two-sided DSB, hence SCEs are a very rare event in this reporter system. (B) RPA1 expression in the DRneo containing CHO cells
following transfection with CMV-empty vector (CMV), I-Sce I-expression vector (I-Sce I) and/or human pcDNA3.1-RPA1. Detergent lysis extracts were
used. The anti-RPA1 antibody used does not cross-react with hamster RPA1. The non-specific cross-reacting band qualitatively illustrates loading
along with the Ponceau stained membrane shown in the lower panel. Endogenous RPA1 expression in T98G human glioblastoma cells is shown as a
comparison to illustrate the extent of ectopic expression of human RPA1 in the various transfections. (C) I-Sce I-induced homologous recombination.
CMV; empty vector, RPA1; RPA1 over-expression, I-Sce I; over-expression of I-Sce I. Cells containing a single integrated copy of the DRneo system
were transfected as indicated and seeded onto plates in the presence of G418 or G418+hygromycin-B (Hyg). Colonies were scored 7–10 days post
transfection. Data represents the mean 6 sd of four experiments. (D) Relative level of total HR (G418 resistant colonies; G418R) following I-Sce I
expression with and without RPA1 over-expression. RPA1 over-expression results in a 1.5–2 fold increase in recombination. Data represents the mean
6 sd of four experiments.
doi:10.1371/journal.pgen.1002247.g005
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RPA1 over-expression affects genomic stability
Our findings with the model HR reporter system suggest that
increased RPA expression was associated with increased recombi-
nation leading to the hypothesis that increased RPA expression
could be associated with increased genome instability. Similarly,
since RAD51 over-expression can also induce significant genomic
instability [23–28], we examined mitotic spreads of our RPA1-
over-expression model cell line (pTUNE-RPA1) for evidence of
elevated genomic instability. Strikingly, significant levels of
chromosome aberrations, fusions/derivatised chromosomes in
particular, were observed in these cells (Figure 6A and 6B). Such
abnormalities would be consistent with aberrant cross-over and/or
ligation events. These aberrations were seen even without
induction with IPTG which is a further indication of some
inherent leakiness in this system and is consistent with elevated
chromatin bound RPA1 seen here (Figure 4D). Despite the
limitations of this artificial cell system, these data do demonstrate
that subtle over-expression of RPA1 can induce significant levels of
genomic instability, specifically elevated levels of derivatised
chromosomes.
Elevated genomic instability and DNA damage sensitivity
in RPA1 over-expressing 17p13.3 duplication syndrome
cells
To examine whether the patient-derived LBLs with RPA1 over-
expression exhibited a similar phenotype we examined mitotic
spreads for chromosomal abnormalities in LBLs from BAB2719
(Dup; RPA1 duplication) compared to BAB2752 (WT; wild-type
normal RPA1 copy number). We also observed elevated levels of
chromosomal aberrations, specifically an over-representation of
chromosomal fusions, in LBLs associated with RPA1 over-
expression (Figure 7A and 7B). These aberrations were increased
following IR-treatment further suggestive of an inability of these
cells to properly repair DSBs (Figure 7B).
Defective and/or aberrant DNA damage-induced HR is also
associated with DNA damaging-induced genomic instability.
Consistent with this we found increased levels of hydroxyurea
(HU)-induced micronuclei (MN) formation in LBLs associated
with RPA1-duplication (Dup; BAB2668, BAB2719) indicative of
increased DNA breakage following replication fork stalling in these
cells (Figure 7C). Furthermore, compromised HR is also
specifically associated with sensitivity to killing by topoisomerase
I inhibitors such as camptothecin (CPT) [36]. Consistent with an
underlying problem with HR associated with RPA1-duplication in
our patient-derived LBLs, we also found that these lines were
sensitive to apoptosis induction following CPT treatment, as
judged by increased levels of sub-G1 cells by propidium iodide
flow cytometry (Figure 7D). Interestingly, for both of these cellular
phenotypes we observed a similar response in BAB2751 (RPA1
haploinsufficient) cells to that of lines over-expressing RPA1 (Dup;
BAB2668 and BAB2719). This suggests that manipulation of
RPA1 levels (increase or decrease) results in increased genomic
instability following DNA damage.
In summary, we found that duplications involving RPA1 are
associated with modest over-expression of RPA1 and also RPA2 at
the protein level, impaired S phase distribution and spontaneously
elevated levels of chromatin bound RPA1, RPA2 and RAD51,
along with attenuated IR-induced RAD51 chromatin retention
following DSB’s suggestive of compromised HR. Using the DRneo
model HR-reporter system we observed a hyper-recombinogenic
phenotype consistent with a shift towards a less genomically
preferable form of HR following modest RPA1 over-expression.
We also found increased levels of complex rearrangements
Figure 6. RPA1 over-expression is associated with elevated levels of chromosomal fusions. (A) Selected images denoting the various
classes of chromosome aberrations observed using the pTUNE-RPA1 model system in T98G glioblastoma cells, including fusions between different
chromosomes, breaks, branched structures and those categorised as ‘other’ typified by the class of terminal fusion shown here within a chromosome.
(B) The pTUNE-RPA1 system exhibited elevated chromosomal instability even without treatment with IPTG (Unt; untreated) suggestive of significant
leakiness in this system. Chromosomal fusions leading to derivatised chromosomes appeared to be the most frequent chromosome aberration
observed in the pTUNE-RPA1 model system. Data represents the mean 6 sd of three experiments. At least 1000 chromosomes were scored per
sample.
doi:10.1371/journal.pgen.1002247.g006
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especially after DSB-induction in patient derived LBLs with RPA1
duplication. Furthermore, these patient derived cells exhibit other
evidence of underlying problems in the DDR such as sensitivity to
CPT and elevated HU-induced micronuclei formation.
Discussion
Variously sized contiguous gene deletions at 17p13.3 are
associated with severe neurodevelopmental phenotypes including
microcephaly and neuronal migration deficits [1]. Recently,
duplications within 17p13.3 have been identified in several
patients exhibiting a milder though distinct phenotype that also
incorporates aspects of autism spectrum disorder [17–19]. Much
attention has focused on characterising the consequence of CNV
of PAFAH1B1/LIS1 in this respect [17–19,37]. Previously, we have
shown that LBLs from some ILS+ individuals and from MDS
patients, all of whom exhibit haploinsufficiency of RPA1, a gene
telomeric to PAFAH1B1/LIS1, exhibit impaired ATR-dependent
Figure 7. RPA1-duplication associated patient cells exhibit elevated genomic instability and sensitivity to DNA damage. (A)
Chromosome spreads from untreated (Unt) or 24 hrs post 2 Gy ionising radiation (IR) from BAB2719 (RPA1 duplication; Dup) showing multiple
chromosome aberrations. Increased levels of complex chromosomal aberrations including fusions were consistently observed in BAB2719. (B)
BAB2719 (RPA1 duplication; Dup) exhibited increased levels of chromosome aberrations compared to BAB2752, an LBL with wild-type (WT) RPA1 copy
number, even in untreated (Unt) cells. These aberrations were further increased in the RPA1 over-expressing line (BAB2719) following IR-treatment as
in (A). Similar to the pTUNE-RPA1 system, fusions and derivatised chromosomes appeared to be the most common chromosome aberration in
BAB2719 associated with RPA1 over-expression (Dup; RPA1 duplication) relative to the BAB2752 wild-type (WT; wild-type RPA1 copy number). Data
represents the mean 6 sd of three experiments. At least 400 chromosomes were scored per sample. (C) HU-induced micronuclei (MN) were
determined in bi-nucleate cells (image inset) for each LBL. Duplication of RPA1 (BAB2668 and BAB2719) and/or haploinsufficiency of RPA1 (BAB2751)
was associated with increased levels of MN compared to BAB2752 wild-type (WT) RPA1 copy number. Data represents the mean 6 sd of three
experiments. (E) Sensitivity to killing by CPT was determined by quantification of the sub-G1 population from propidium iodide flow cytometry
profiles 72 hrs post treatment (CPT 10 mM). Duplication of RPA1 (BAB2668 and BAB2719) and/or haploinsufficiency of RPA1 (BAB2751) was associated
with increased sensitivity to killing by CPT compared to BAB2752 wild-type (WT) RPA1 copy number. Data represents the mean 6 sd of three
experiments.
doi:10.1371/journal.pgen.1002247.g007
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DDR [6]. Here, we find that for the reciprocal situation, that is, in
LBLs from patients associated with duplication of RPA1, we
observed a distinct DDR abnormality impacting upon HR.
The RPA1–3 complex is a fundamental functional component
of many DNA processes involving the generation of single
stranded DNA [8]. RPA1–3 complex is essential for several
DNA repair pathways (e.g nucleotide excision repair, mismatch
repair, base excision repair), for DNA replication and recombi-
nation events [12–16]. Therefore, a plausible assumption would be
that a significant reduction in RPA expression/function results in
embryonic lethality. Attempts to create knockout mice for RPA1
have not been reported. Nevertheless, mice bearing a semi-dominant
heterozygous mis-sense mutation in Rpa1 (Rpa1L230P) exhibit gross
genomic rearrangements and are highly cancer prone (Rpa1L230P
homozygosity is cell lethal) [38]. Hence, precedent exists for
altered RPA1, and likely, consequently RPA complex function,
impacting on genomic stability at the organismal level. Further-
more, forced over-expression of RPA1 can cause genomic
instability, at least in cancer cell lines [21].
There are several instances whereby over-expression of various
DDR and/or cell cycle components disrupts or adversely affects
the fundamental cellular processes/pathways in which they are
functional components. For example, over-expression of CDC25A
phosphatase is thought to be an important contributor to
uncontrolled cell cycle progression from G2 into M frequently
observed in certain malignancies [24,25]. Over-expression of
RAD51 and RAD52 has been found to reduce DSB-induced HR
in mammalian cells [28]. Indeed, over-expression of separase or
the SAC component MAD2 results in aneuploidy and malignancy
in mice, consistent with defective SAC activity [26,27]. Our
findings suggest that a modest over-expression of RPA1 in LBLs
derived from individuals with duplications in 17p13.3 involving
RPA1 results in an abnormal distribution of cells in S phase,
adversely impacts on HR and is associated with elevated
chromosomal instability and sensitivity to DNA damaging agents.
RPA1 is thought to be of particular importance for RPA
heterotrimeric function since it can bind DNA independently of the
other subunits and contains the greatest surface area available to
mediate protein-protein interaction [39]. Interestingly, we found
that RPA2 also appeared to be over-expressed in our patient-
derived LBLs associated with RPA1 duplication, potentially
suggesting elevated levels of RPA complex in this context. This
could have adverse implications for coordinating subsequent DNA
processing pathways. For example, during HR, a ‘handover’
between RPA1–3 complex coated ssDNA and RAD51 must occur
to allow RAD51 nucleofilament formation for strand invasion. As
RPA1 can bind RAD51 directly, an excess of chromatin bound
RPA complex could interfere with the timing, coordination and/or
efficiency of this ‘handover’ (Figure 8). A direct consequence of this
could be either uncontrolled elevated or reduced overall HR
Figure 8. A summary model of how elevated RPA1 may adversely impact on homologous recombination. Homologous recombination
(HR) is engaged when an overt DSB occurs at certain phases of the cell cycle or following replication fork stalling, say upon encountering a single
strand break, or after overt replication fork collapse. RPA heterotrimeric complexes are displaced by RAD51 to facilitate strand invasion and homology
searching. Our data indicates that modestly increased RPA1 levels as occurs in LBLs from individuals exhibiting duplication of RPA1, is also associated
with elevated RPA2 suggestive of increased levels of RPA complex. This excess RPA complex, perhaps by sequestering binding partners, can result in
delayed S phase progression and impact upon HR sub-pathway choice, potentially favouring more aberrant forms of recombination such as SSA and/
or GC with crossing-over thereby promoting spurious fusions likely associated with loss of genetic material. This subtly elevated RPA1 level and
consequently elevated RPA complex can result in elevated levels of chromosomal instability, derivatised chromosomes and enhanced sensitivity to
DNA damaging agents.
doi:10.1371/journal.pgen.1002247.g008
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capacity and/or a preference for other forms of recombinational
repair, aside from gene conversion (GC). Data from our patient-
derived LBLs show spontaneously elevated RAD51 on chromatin
but attenuated IR-induced recruitment. Furthermore, our data
generated following transient RPA1 over-expression in the DRneo
system indicates a hyper-recombinogenic phenotype (i.e. total HR
increases whilst levels of GC without crossing-over remain fairly
constant). Interestingly, RPA has recently been shown to be
required for SSA, at least in Xenopus [34]. One possible
interpretation of the DRneo system-derived data is a shift towards
an elevated level of SSA and/or GC with crossing-over, both of
which involved loss of genetic material. The elevated levels of
derivatised chromosomes observed in mitotic spreads from the
RPA1-duplication associated LBLs and in the pTUNE-RPA1
system cells are consistent with aberrant cross-over and/or ligation
events. A hyper-recombinogenic phenotype can have serious
consequences for genome stability. For example, elevated ‘muta-
genic’ HR has been implicated as pathophysiological contributor to
disease progression in haematological malignancies such as Chronic
Myelogenous Leukaemia and Multiple Myeloma [40–42].
The complex clinical spectrum of 17p13.3 microduplication
syndrome is undoubtedly a consequence of the combined increased
copy number of several genes within 17p13.3, although some
candidates may have greater impacts than others [17–19]. The
specific pathological connection between increased RPA1 expression
and the clinical features of those respective patients is unclear.
Nevertheless, the cellular phenotypes described here, including
impaired S phase and suboptimal HR, could adversely influence
apparently unrelated biological pathways by affecting gene expres-
sion. For example, components of the DNA replication machinery
have been shown to influence epigenetic control of gene silencing
[43]. Furthermore, suboptimal/aberrant HR could conceivably
ultimately alter the genomic architecture resulting in unanticipated
cis and/trans effects on the expression of other genes. Interestingly,
RPA1 has been implicated in such ‘allelic phasing’ together with TP53
with respect to carcinogenesis [44]. Congenitally elevated genomic
instability is often associated with cancer predisposition, although
this has not been noted in either 17p13.3 duplication syndrome
patients associated with RPA1-duplication [17]. Obviously there are
too few patients to make any definitive conclusions, although the
cellular defects presented here may warrant consideration in this
respect. Clearly, further work is required to untangle the clinical
consequences of increased RPA1 expression.
In conclusion, we have found that LBLs derived from patients
with duplications in 17p13.3 specifically incorporating RPA1 exhibit
a modest over-expression of RPA1 and RPA2 which is associated
with attenuated S phase transit, attenuated IR-induced RAD51
chromatin recruitment, elevated chromosomal instability, increased
HU-induced MN formation and sensitivity to killing by CPT. All of
these phenotypes are consistent with an inefficient HR pathway.
Furthermore, using various model cell systems we showed that
modest conditional over-expression of RPA1 alone impacts on IR-
induced RAD51 chromatin retention and I-SceI-induced HR in a
reporter construct, the latter phenotype indicative of a hyper-
recombinogenic shift towards alternative forms of recombination
coincident with elevated chromosomal fusions. Collectively, our
findings highlight a novel association between impaired DDR and
CNV resulting in copy number gain of RPA1.
Materials and Methods
Cell lines
EBV-transformed patient-derived lymphoblastoid cell lines
(LBLs) were cultured in RPMI with 15% FCS, L-Gln and
antibiotics (Pen-Strep) at 5% CO2. T98G glioblastoma cells were
maintained in MEM supplemented with 10% FCS, pyruvate and
non-essential amino acids. Chinese Hamster Ovary cell lines
(CHOs) were cultured in 10% DMEM, L-Gln and antibiotics
(Pen-Strep) at 5% CO2.
Whole cell extracts
Urea extraction: Cells were lysed in 150 ml urea buffer (9 M
urea, 50 mM Tris-HCl at pH 7.5 and 10 mM 2-mercaptoetha-
nol), followed by 15 s sonication, 30% amplitude using a micro-tip
(SIGMA-Aldrich). The supernatant was quantified by Bradford
Assay.
Detergent lysis: Cell pellets were incubated for 1 hr on ice in
buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl,
2 mM EDTA, 2 mM EGTA, 25 mM NaF, 25 mM b-glycer-
olphosphate, 0.1 mM Na-orthovanadate, 0.2% Triton X-100,
0.3% IGEPAL and protease inhibitor cocktail tablets as indicated
by manufacturer (Roche). The supernatant was quantified by
Bradford Assay.
Chromatin extracts
Cells were harvested 24 hr after 10 Gy gamma irradiation.
Gamma irradiation was performed using a 137Cs c-ray source at a
dose rate of 8 Gy/min. Cells were lysed in detergent lysis buffer
(above) for 1 hr on ice followed by 15 min in high-salt IP buffer
(an extra 500 mM NaCl added to the regular IP buffer). The cell
pellet was re-suspended in urea buffer (see WCE above) and
sonicated for 15 s. The supernatant was quantified by Bradford
Assay.
Protein quantification from Western blotting
Western blots were developed using ECL (Pierce) in a
luminescent image analyser, Image Quant LAS 4000 (GE
Healthcare). This analyser ensures all bands are in the linear
range (during the developing any saturated bands are highlighted
so that the exposure can be decreased). Image Quant TL 7.01
quantification software was used to quantify the band intensities.
Alternatively, following ECL, Western blots were developed
using film and the scanned images quantified with Image J
software.
Plasmids
Custom assembled pTUNE-RPA1 was obtained from Origene
and stable T98G clones were obtained following transfection with
MetafectenePro (Biontex Laboratories GmbH) and selection in
G418 (1 mg/ml). For inductions, cells were treated with 500 mM
IPTG for 3 hrs.
Antibodies
Anti-RPA1 (Ab-1 #NA13) and anti-RPA2 (Ab-2 #NA18)
antibodies were from Calbiochem. Anti-RAD51 (H-92) was from
Santa Cruz. Anti-H3 was from Cell Signaling and anti-H2B was
from Millipore. Anti-BrdU-FITC conjugated antibody (347583)
was from Becton Dickinson.
G2-M cell cycle checkpoint
UV irradiation was carried out using a UV-C source (0.6 J/m2/
s). Cells were irradiated with 5 J/m2 UV-C in PBS and
immediately seeded into complete medium supplemented with
1.5 mM nocodazole for 24 hr. Cells were pelleted, swollen with
75 mM KCl for 10 min before fixing in Carnoy’s solution
(methanol: glacial acetic acid 3:1), before counterstaining with
49-6-Diamidino-2-phenylindole (DAPI). Cells were Cytospun
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(Shandon) onto poly-L-lysine coated slides and mounted with
Vectashield (Vector Labs). Slides were scored using a Zeiss
AxioPlan microscope.
Spindle assembly checkpoint
Exponentially growing LBLs were treated with 1.5 mM
nocodazole for 24 hrs then fixed in 70% ice cold ethanol prior
to propidium iodide staining and analysis by flow cytometry.
Flow cytometry
LBLs were fixed in ice-cold 70% ethanol for 24 h and re-
suspended in PBS containing 0.5% Tween-20, 10 mg/ml propi-
dium iodide and 500 mg/ml RNase A. Data were collected using a
Becton Dickinson FACS Calibur machine and were analysed with
CellQuest software. For BrdU incorporation cells were labelled
with 50 mM BrdU for 15 min. Incorporated BrdU was detected
using FITC-conjugated anti-BrdU antibody (Becton-Dickson).
DRneo system and homologous recombination
ERCC1.17 DRneo CHO cells were grown in 10% DMEM
supplemented with 3 mg/ml Blasticidin-S and 0.05 mM hygro-
mycin B [33]. Assay: 56105 cells were seeded in 6 cm plates. Next
day cells were co-transfected with 2 mg RPA1 and 2 mg I-SceI (or
CMV control) using MetafectenePro, according to the manufac-
turer’s protocol. 24 hr after transfection cells were put into
selection. For the recombination frequencies, 56104 cells per
10 cm plate were seeded with 1 mg/ml G418 and/or 0.5 mg/ml
hygromycin-B. 103 cells were seeded to determine the cloning
efficiency. Plates were incubated for 7 days, after which they were
stained with methylene blue.
DNA damage sensitivity
Exponentially growing LBLs were treated with 10 mM camp-
tothecin (CPT) and incubated for 72 hrs, fixed (ice cold 70%
ethanol), stained with propidium iodide and sub-G1 cells
quantified by flow cytometry.
Micronuclei
Cells were treated with 1 mM HU for 4 hrs before incubation
for 24 hrs in 5 mg/ml cytochalasin B for bi-nucelate formation.
Micronuclei were scored in bi-nucleated cells by immunofluores-
cence microscopy (Zeiss AxioPlan) following swelling in KCl
(75 mM 10 mins), fixation (Carnoy’s fix; 3:1 methanol:acetic acid.
10 mins) and staining with DAPI and acridine orange (2 mg/ml).
Chromosome analysis
The pTUNE-RPA1 T98G cells, and wild type T98G cells, were
induced with 500 mM IPTG for 3 hr before adding 0.2 mg/ml
colcemid for 4 hr prior to harvesting. Cells were swollen (75 mM
KCl 10 mins) and then fixed in Carnoy’s fixative (10 mins) prior to
being dropped onto slides from approx 50 cm above. The slides
were air dried and Giemsa stained according to the manufactur-
er’s (Sigma) protocol. Images were captured on a Zeiss AxioPlan
microscope. Chromosomes spreads were scored blinded according
to the following criteria; fusions between different chromosomes,
breaks, branched structures and ‘other’ (a terminal fusion within a
single chromosome). The results were represented as aberrations
per 100 chromosomes, rather than per metaphase due to the
aneuploid nature of T98G. LBLs were treated with 2 Gy ionising
radiation (IR) and allowed to recover for 24 hrs. The IR treated
(IR) and untreated control (Unt) cells were treated with 0.2 mg/ml
colcemid for 4 hr prior to harvesting. Cells were swollen (75 mM
KCl 10 mins), fixed (Carnoy’s), Giemsa stained and analysed as
above.
Supporting Information
Figure S1 Duplication of RPA1 results in RPA1 and RPA2 over-
expression. Western blot analysis for expression of RPA1 (left-
hand panel), RPA2 (middle panel) and MCM2 (right-hand panel)
using urea-derived whole cell extracts from patient derived LBLs.
LBLs with wild-type RPA1 copy number are shown in black, those
with RPA1 duplication in red and those with RPA1 haploinsuffi-
ciency in blue. BAB2705 (WT; wild-type RPA1 copy number) and
BAB2678 (WT; wild-type RPA1 copy number) are LBLs from
patients with a duplication in 17p13.3 not involving RPA1 (see
Figure 1A). Both BAB2719 (Dup; RPA1 duplication) and
BAB2668 (Dup) exhibit duplications involving RPA1, whilst
BAB2751 (Del; RPA1 heterozygous deletion) exhibits RPA1
haploinsufficiency. Each panel shows sequential loading of
2.5 mg, 5 mg and 10 mg extract.
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